0001415889-18-000657.txt : 20180420 0001415889-18-000657.hdr.sgml : 20180420 20180420183542 ACCESSION NUMBER: 0001415889-18-000657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180418 FILED AS OF DATE: 20180420 DATE AS OF CHANGE: 20180420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YANG MICHAEL J. CENTRAL INDEX KEY: 0001702283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 18767705 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 3611 VALLEY CENTRE DRIVE,SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 form4-04202018_030428.xml X0306 4 2018-04-18 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001702283 YANG MICHAEL J. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 false true false false EVP AND CCO Stock Option (right to buy) 19.98 2018-04-18 4 A 0 60000 0 A 2028-04-17 Common Stock 60000 60000 D 25% of the shares subject to the Stock Option vest and become exercisable on April 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. /s/ Glenn F. Baity, Attorney-in-Fact 2018-04-20